Gutiérrez, Antonio; Zeberio, Izaskun; Peñalver, Francisco-Javier; Martínez-Barranco, Pilar; Pérez, Sandra; Morillo, Daniel; Martin, Xabier; Nicolás, Concepción; Ferrero, Ainara; Jiménez-Ubieto, Ana; Bastos-Oreiro, Mariana; Dávila-Valls, Julio; Calle, María-Victoria; Pérez, María; Rodríguez, Guillermo; Alonso, Aranzazu; García-Noblejas, Ana; Sánchez-Argüello, Diana; Knight, Teresa; Fernández, Ángeles; López, Javier; Pérez-de-Oteyza, Jaime; González-de-Villambrosia, Sonia; Pérez, Elena; Marín, Alejandro; Navarro, María-Belén; Fernández, Rubén; Gómez, Pilar; Hueso, José-Antonio; Peñarrubia-Ponce, María-Jesús; Bravo, Pilar; García-Belmonte, Daniel; de-la-Nuez, Haridian; Nistal, Sara; Abrisqueta, Pau; Iban, Fernanda; Palomera, Luis; Donato, Eva; Provencio, Andrea; Infante, María-Stefania; González-Barca, Eva
(ELSEVIER, 2025-10-14)
Relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL) remains challenging to treat, especially in patients ineligible for intensive therapy or chimeric antigen receptor T cells. Tafasitamab plus lenalidomide (T/L) ...